Donald Trump’s Presidency Could Unleash a Pharma Merger Boom — Fortune

Biotechnology companies, whose U.S. shares soared Wednesday after Republican Donald Trump’s presidential election, may soon see another benefit: an uptick in biotech M&A. A potential influx of foreign cash and improved stock valuations under the Trump administration would likely boost dealmaking in the industry, which has been anemic ever since political rhetoric against high drug…

via Donald Trump’s Presidency Could Unleash a Pharma Merger Boom — Fortune

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s